Transcatheter Aortic Valve Implantation Market 2023 Demand Product Types, Application, Regions 2031

The global transcatheter aortic valve implantation market revenue was US$ 5,197 million in 2021. The global transcatheter aortic valve implantation market revenue is forecast to reach US$ 16,937 million by 2030, registering a compound annual growth rate (CAGR) of 14.0% during the forecast period from 2022 to 2030.

Transcatheter aortic valve replacement is also known as transcatheter aortic valve implantation (TAVI). It is a minimally invasive procedure performed on high-risk patients who suffer from aortic stenosis. The TAVI procedure involves the implantation of transcatheter aortic valves to restore the aortic valves' blood flow capability.

Download free sample of this report :-https://www.quadintel.com/request-sample/transcatheter-aortic-valve-implantation-tavi-market/QI040

Factors Influencing Market Growth

The global transcatheter aortic valve implantation market growth is primarily due to an increase in aortic stenosis prevalence, increased demand for various TAVI procedures, and advances in technology in the field.A rise in geriatrics populations is driving the global TAVI market growth since they are more likely to suffer from aortic stenosis.

Increasing awareness about early diagnosis and technological advancements in TAVI valves propel the global market's growth.

Regulatory barriers to transcatheter aortic valve approval and high costs associated with TAVI may negatively impact the global market's growth.

Several growth opportunities for the global transcatheter aortic valve implantation (TAVI) market will increase during the forecast period, including the use of TAVI systems for new indications, the rise in healthcare spending in emerging economies, and the increasing interest of key players in this field.

Impact Analysis of COVID-19

The COVID-19 pandemic impacted access to transcatheter aortic valve implantation for people living with aortic stenosis. The pandemic has prompted hospitals to implement protocols that minimize the use of anesthesiologists, ventilators, operating rooms, and intensive care beds. COVID-19 participants who underwent TAVI dealt with time delays, emergency procedures, and adverse outcomes.

Regional Insights

Europe held dominant in the transcatheter aortic valve implantation market and is forecast to remain dominant during the forecast period. It is due to the presence of key players, the developed healthcare sector, and advancements in valve technology.

TAVI in Europe has experienced growth due to an increase in cases of severe aortic stenosis, an increase in high-risk patients, and improved awareness among patients and physicians about the benefits of transcatheter aortic valves. A favorable reimbursement policy in certain European nations also contributes to adopting TAVI procedures in this region.

North America is forecast to register the highest CAGR in the global market during the forecast period. Due to increased health care investments by manufacturers and high R&D expenditures by companies. In addition, the prevalence of coronary artery disease, hypertension, or heart failure contributes to the growth of the transcatheter aortic valve implantation market in North America.

Request full Report Description, TOC, Table of Figure, Chart, etc : -https://www.quadintel.com/request-sample/transcatheter-aortic-valve-implantation-tavi-market/QI040

Leading Competitors

The leading prominent companies profiled in the global transcatheter aortic valve implantation market are:

Abbott Laboratories
Boston Scientific Corporation
Blue Sail Medical Co. Limited
Bracco Group
Edward Lifesciences
JC Medical Incorporated
JenaValve Technology Incorporated
Medtronic Plc
Meril Life Sciences
Venus MedTech HangZhou Incorporated
Other Prominent Players

Scope of the Report

The global transcatheter aortic valve implantation market segmentation focuses on Procedure, End-User, and Region.

Segmentation based on Procedure

Transfemoral Procedure
Subclavian Procedure
Others

Download Free Sample Report -https://www.quadintel.com/request-sample/transcatheter-aortic-valve-implantation-tavi-market/QI040

Segmentation based on End-User

Hospitals
Ambulatory Surgical Centers
Others

Segmentation based on Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America

Request full Report :- https://www.quadintel.com/request-sample/transcatheter-aortic-valve-implantation-tavi-market/QI040

About Quadintel:

We are the best market research reports provider in the industry. Quadintel believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today's competitive environment. Quadintel is a 'one-stop solution' for individuals, organizations, and industries that are looking for innovative market research reports.

We will help you in finding the upcoming trends that will entitle you as a leader in the industry. We are here to work with you on your objective which will create an immense opportunity for your organization. Our priority is to provide high-level customer satisfaction by providing innovative reports that enable them to take a strategic decision and generate revenue. We update our database on a day-to-day basis to provide the latest reports. We assist our clients in understanding the emerging trends so that they can invest smartly and can make optimum utilization of resources available.

Get in Touch with Us:

Quadintel:
Email:sales@quadintel.com
Address: Office - 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
Tel: +1 888 212 3539 (US - TOLL FREE)
Website : https://www.quadintel.com/

This release was published on openPR.